INCY
NASDAQ · Biotechnology
Incyte Corp
$120.56
+2.18 (+1.84%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+10.58%
1Y
+53.80%
YTD
+18.87%
Open$118.56
Previous Close$118.38
Day High$120.88
Day Low$117.38
52W High$132.60
52W Low$76.45
Volume—
Avg Volume2.49M
Market Cap24.40B
P/E Ratio15.14
EPS$7.85
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$101.74
Above
SMA 200
$86.15
Above
RSI (14)
51.1
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Hold
33 analysts
Price Target
+71.5% upside
Current
$120.56
$120.56
Target
$206.81
$206.81
$125.25
$206.81 avg
$260.19
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 5.19B | 4.52B | 3.83B |
| Net Income | 1.30B | 1.02B | -346,012,622 |
| Profit Margin | 25.0% | 23.8% | -9.0% |
| EBITDA | 1.55B | 1.29B | -409,317,505 |
| Free Cash Flow | — | — | -346,886,835 |
| Rev Growth | +14.8% | +14.8% | -9.6% |
| Debt/Equity | 0.01 | 0.01 | 0.64 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |